Literature DB >> 30337174

Hepatitis A seroprevalence in adolescents and young adults in Mexico: A 2012 National Health and Nutrition Survey analysis.

Hugo López-Gatell1, Lourdes García-García1, Gabriela Echániz-Avilés1, Pablo Cruz-Hervert1, María Olamendi-Portugal1, Deyanira Castañeda-Desales1, Miguel Ángel Sanchez-Alemán1, Martín Romero-Martínez2, Rodrigo DeAntonio3, Maria Yolanda Cervantes-Apolinar4, Ricardo Cortes-Alcalá5, Celia Alpuche-Aranda6.   

Abstract

To describe hepatitis A virus (HAV) seroprevalence and associated factors in adolescents (10-19 years) and young adults (20-25 years) in different Mexican regions, using 2012 National Health and Nutrition Survey data. A random selection of 1581 serum samples was analyzed. Weighted HAV seroprevalence with 95% confidence intervals (95%CI) and its association with sociodemographic factors were estimated. Mean weighted HAV seroprevalence was 69.3% (95%CI: 64.8-73.4) overall, with 58.8% (95%CI: 53.4-64.1) in adolescents and 83.0% (95%CI: 75.3-88.7) in young adults. By age of 10, 46.7% (95%CI: 33.9-60.0) were seropositive and by age of 15, 52.8% (95%CI: 36.5-68.5), corresponding to intermediate endemicity nationally. Factors associated with HAV seropositivity (adjusted odds ratio, aOR) included: lower socioeconomic status (SES) (aOR = 4.09 for low and aOR = 2.31 for medium versus high SES), older age (aOR = 0.29 for adolescents versus young adults), living in the South (aOR = 2.12 versus Central Mexico) or in rural areas (aOR = 2.25 versus urban areas). Regional differences and increased seroprevalence of HAV in marginalized populations present an important public health issue, as a relatively large proportion of young adults are susceptible to infection. The burden of symptomatic disease must be addressed further to support specific programs of continued sanitation and education improvement, and the possibility of vaccination in more susceptible regions.
Copyright © 2018 GlaxoSmithKline Biologicals SA. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Hepatitis A; Mexico; Seroprevalence

Mesh:

Substances:

Year:  2018        PMID: 30337174     DOI: 10.1016/j.vaccine.2018.10.037

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  3 in total

1.  A 2019 Outbreak Investigation of Hepatitis A Virus Infections in the United States Linked to Imported Fresh Blackberries.

Authors:  Monica McClure; Johnson Nsubuga; Martha P Montgomery; Erin Jenkins; Alvin Crosby; Daniela Schoelen; Colin Basler; Sumathi Ramachandran; Yulin Lin; Guo-Liang Xia; Yury Khudaykov; Vilasini Suktankar; Angela Wagley; Vincent Thomas; Jacquelina Woods; Leslie Hintz; Janete Oliveira; Ana Lilia Sandoval; Justin Frederick; Blake Hendrickson; Laura Gieraltowski; Stelios Viazis
Journal:  Food Environ Virol       Date:  2022-07-23       Impact factor: 4.034

2.  Burden of disease and associated complications of hepatitis a in children and adults in Mexico: A retrospective database study.

Authors:  Adriana Guzman-Holst; Gerardo Luna-Casas; Ana Burguete Garcia; Vicente Madrid-Marina; Maria Yolanda Cervantes-Apolinar; Anar Andani; Gloria Huerta-Garcia; Gilberto Sánchez-González
Journal:  PLoS One       Date:  2022-05-18       Impact factor: 3.752

Review 3.  Hepatitis A vaccination and its immunological and epidemiological long-term effects - a review of the evidence.

Authors:  Christian Herzog; Koen Van Herck; Pierre Van Damme
Journal:  Hum Vaccin Immunother       Date:  2020-12-16       Impact factor: 3.452

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.